Containing Acetylenic Amino Acids

Total Page:16

File Type:pdf, Size:1020Kb

Containing Acetylenic Amino Acids PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/83181 Please be advised that this information was generated on 2021-09-23 and may be subject to change. Cyclic Enediyne-Containing Amino Acids Een wetenschappelijke proeve op het gebied van de Natuurwetenschappen, Wiskunde en Informatica Proefschrift ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof. mr. S. C. J. J. Kortmann, volgens besluit van het College van Decanen in het openbaar te verdedigen op vrijdag 4 februari 2011 om 15.30 uur precies d o o r Jasper Kaiser geboren op 27 december 1977 te Heidelberg (Duitsland) P r o m o t o r : Prof. dr. Floris P. J. T. Rutjes Copromotor: Dr. Floris L. van Delft Manuscriptcom m issie: Prof. dr. ir. Jan C. M. van Hest Dr. Dennis W. P. M. Löwik Dr. Sape S. Kinderman (Universiteit van Amsterdam) Paranim fen: Danny Gerrits M a r k D a m e n Kaftontwerp: Studio Appeltje-S D r u k k e r ij: Ipskamp Drukkers ISBN/EAN: 978-90-9025901-7 Die gefährlichste Weltanschauung ist die Weltanschauung derer, weiche die Weit nie angeschaut haben. Alexander von Humboldt However beautiful the strategy, you should occasionally look at the results. Winston Churchill Table of Contents List of Abbreviations vi C hap ter 1: Introduction 1 1.1 General introduction 2 1.2 Naturally occurring enediynes 2 1.3 Terminal acetylenic amino acids 10 1.4 Purpose and outline of the thesis 17 1.5 Acknowledgement 17 1.6 References and notes 17 C hap ter 2: Synthesis of Cyclic Enediyne-Containing Amino Acids 21 2.1 Introduction 22 2.2 Previous work in our group 23 2.3 Enediynes based on propargylglycine 25 2.4 Eleven-membered cyclic enediynes from homopropargylglycine 31 2.5 Pyridine-fused enediynes 32 2.6 Conclusion 37 2.7 Acknowledgements 38 2.8 Experimental section 38 2.9 References and notes 51 C hap ter 3: Characterization and Reactivity of Cyclic Enediyne-Containing Amino Acids 53 3.1 Introduction 54 3.2 Structural description of the cyclic enediyne-containing amino acids 57 3.3 Kinetics and half-life determinations 60 3.4 Peptide couplings involving cyclic enediyne-containing amino acids 65 3.5 Bergman Cyclizations of the nosyl variant, the free amine and the dipeptides 70 3.6 The Bergman Cyclization as synthetic tool 73 3.7 Conclusion 74 3.8 Acknowledgement 74 3.9 Experimental section 74 3.10 References and notes 83 C hap ter 4: Ca-Tetrasubstituted Enediyne Amino Acids Based on a-Methyl-a-Propargylglycine 85 4.1 Introduction 86 4.2 Towards enantiopure a-propargylalanine 88 4.3 Cyclic enediyne-containing a-methyl amino acids 91 4.4 Towards peptide couplings of a-Me enediynic amino acids 93 4.5 Kinetics and half-life determinations 96 4.6 Conclusion 98 4.7 Outlook 99 iv 4.8 Acknowledgements 99 4.9 Experimental section 99 4.10 References and notes 108 C hap ter 5: Preparation and Evaluation of a-CF3-Containing Acetylenic Amino Acids 111 5.1 Introduction 112 5.2 Towards a-CF3-a-amino acids via trifluoromethyl ketones 114 5.3 Preparation of acetylene-containing a-CF3-a-amino acids 117 5.4 Enzymatic resolution of TfmPG 119 5.5 Coupling reactions of TfmPG 120 5.6 Miscellaneous reactions of TfmPG 122 5.7 Towards cyclic CF3-containing enediyne amino acids 123 5.8 Conclusion 124 5.9 Acknowledgements 125 5.10 Experimental section 125 5.11 References and notes 135 C hapter 6: Towards Enediynes Linked to Plasmonically Heated Nanoparticles: a Possible Future Direction for Enediyne-Based Therapies 137 6.1 Introduction 138 6.2 Plasmonically heated nanoparticles linked to enediynes 139 6.3 Synthesis 140 6.4 Discussion and conclusion 141 6.5 Acknowledgements 142 6.6 Experimental section 142 6.7 References and notes 143 Summary / Samenvatting 145 1.1 Summary 146 J..2 Samenvatting 150 Dankwoord / Danksagung / Acknowledgements 155 About the Author 159 Appendix: Color Illustrations 160 v List of Abbreviations AA amino acid ETFAA ethyl 4,4,4-trifluoro- AMAA a-methyl-a-amino acid acetoacetate AuNP gold nanoparticle Fmoc 9-fluorenylmethoxycarbonyl B base HATU 0-(7-azabenzotriazol-1-yl)- BC Bergman Cyclization N,N,N' ,N' -tetramethyl- uronium hexafluorophosphate Boc t-butoxycarbony HOAt 1 -hydroxy-7-azabenzotriazole i 1 1 1 di - bi s( P3 P3 N o 0 u 0 yl) BOP-Cl 2 x x HOBt 1 -hydroxybenzotriazole p phosphinich o s ph hin ic chloridech br HPLC high pressure liquid chromatography BSA N,0-bis(trimethylsilyl)- acetamide HRMS high resolution mass spectroscopy CAL calicheamicin IR infrared cat catalytic / catalyst coupling constant (NMR) Cbz benzyloxycarbonyl J KHMDS potassium CHD cyclohexa-1,4-diene bis(trimethylsilyl)amide CI chemical ionization LCMS liquid chromatography - mass Cy cyclohexyl spectrometry d doublet (NMR) LiHMDS lithium 6 chemical shift (NMR) bis(trimethylsilyl)amide DBU 1,8-diazabicyclo[5.4.0]undec- m multiplet (NMR) 7-ene MS molecular sieves DAST (diethylamino)sulfur Ms mesyl; methanesulfonyl trifluoride MSC Myers-Saito cyclization DCC N,N' -dicyclohexyl- m/z mass-to-charge ratio carbodiimide NaHM DS sodium DDQ 2,3-dichloro-5,6-dicyano-1,4- bis(trimethylsilyl)amide benzoquinone NCS neocarzinostatin DEAD diethyl azodicarboxylate Ns nosyl; DIAD diisopropyl azodicarboxylate 2-nitrobenzenesulfonyl d iad - h 2 diisopropyl hydrazine-1,2- nonaflyl; dicarboxylate N f nonafluorobutanesulfonyl D IPCD I diisopropyl carbodiimde NMO N-methylmorpholine-N-oxide DiPEA diisopropylethylamine NMR nuclear magnetic resonance DMAP 4-dimethylaminopyridine Nu nucleophile DME 1, 2 -dimethoxyethane PG protecting group DMF N,N-dimethylformamide PPAA propylphosphonic acid DMAD dimethyl acetylene- anhydride; dicarboxylate 2,4,6-tripropyl-1,3,5,2,4,6- DMSO dimethyl sulfoxide trioxatriphosphorinane-2,4,6- d.r. diastereomeric ratio trioxide EDC 1-ethyl-3-(3-dimethyl- Piv pivaloyl aminopropyl)-carbodiimide py pyridine hydrochloride PyBrO P bromotripyrrolidino- Edy See Chapter 3, Figure 9 phosphonium hexafluoro- ee enantiomeric excess phosphate EI electron impact ionization q quartet (NMR) equiv equivalents quant quantitative ESI electrospray ionization rac racemic ESP esperamicin RCM ring closing metathesis vi R/ retention factor rfx reflux rt room temperature s singlet (NMR) ssp. subspecies (taxonomy) t triplet (NMR) t l/2 half life time TBAF tetra-n-butylammonium fluoride TBAI tetra-n-butylammonium iodide TBDMS t-butyldimethylsilyl TEM transition electron microscopy THF tetrahydrofuran Tf trifluoromethanesulfonyl TFA trifluoroacetic acid TFAA trifluoroacetic anhydride Tfm trifluoromethyl TfmPG a-trifuoromethyl-a- propargylglycine TLC thin layer chromatography TMEDA N,N,N' ,N' -tetramethylethane- 1,2-diamine TMS trimethylsilyl / trimethylsilane tol toluyl Ts tosyl, 4-toluenesulfonyl var. variant (taxonomy) vii viii Introduction Abstract The concept of cyclic enediyne-containing amino acids is introduced, followed by a synopsis covering the most relevant elements of the history, chemistry and biology of naturally occurring enediynes. In addition, a concise overview of applications of acetylenic amino acids relevant to this thesis is provided. An outline of the thesis concludes the chapter. 1 Chapter 1 1.1 General introduction Natural enediynes are compounds containing a (Z)-hexa-3-en-1,5-diyne (1, Figure 1) or a closely related structural motif, and they rank among the most powerful antitumor and antibiotic agents found in Nature. Their active principle relies on the thermal generation of radicals. These are capable of damaging nearby DNA by abstraction of hydrogen atoms from deoxyribose units of the sugar phosphate backbone, causing single- and double-strand scissions and ultimately cell death. Furthermore, naturally occurring enediynes belong - from a scientist's point of view - to the most fascinating chemical entities ever isolated; their chemistry, mode of action and probably also their structural complexity have bewitched and intrigued many a chemist. Considering the tremendous cytotoxic properties of the natural compounds, making available simplified enediynes endowed with versatile handles for derivatization or for accommodation in functional complexes is of general interest. The incorporation of amino acids into enediynes would meet the demands for such versatility by virtue of the amino and the carboxylic acid functionalities. In line with our longstanding experience in the application of acetylenic amino acids ,2,3 we envisaged that this class of amino acids would make for suitable building blocks for enediyne-containing amino acids. Finally, as the activity of the enediyne core benefits from confinement into a cyclic s tr u c tu r e (vide infra), the idea of cyclic enediyne-containing amino acids was conceived (2, Figure 1). 1 2 (Z)-hexa-3-en-1,5-diyne cyclic enediyne-containing amino acids F ig u re 1 1.2 Naturally occurring enediynes 1.2.1 History The story of the natural enediynes, as far as humankind is concerned, began in 1965 when Ishida et al. reported the isolation of neocarzinostatin (NCS), an "antitumor antibiotic of high molecular weight" as they put it, from Streptomyces carzinostaticus var. F-41.4 This compound was later characterized as a 1:1 complex of a protein 2 Introduction component (apoprotein) and a chromophoric molecule, and it was established that the cytotoxicity of neocarzinostatin mainly resided on the chromophore .5 Despite the interesting biological activity, twenty years had to pass before the structure of the chromophore was elucidated by E d o et al. in 1985 (3, Figure 2 ).6 NCS neocarzinostatin chromophore Figure 2 The neocarzinostatin chromophore. Even after the elucidation of the intriguing enyne-cumulene moiety, the interest of the synthetic community in neocarzinostatin remained lukewarm. Aside from the then unresolved absolute stereochemistry, the structure quite possibly seemed too unlikely to the majority of chemists.
Recommended publications
  • Structure¬タモactivity Relationship Study at C9 Position of Kaitocephalin
    Bioorganic & Medicinal Chemistry Letters 26 (2016) 3543–3546 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Structure–activity relationship study at C9 position of kaitocephalin Yoko Yasuno a, Makoto Hamada a, Yuya Yoshida a, Keiko Shimamoto b, Yasushi Shigeri c, ⇑ Toshifumi Akizawa d, Motomi Konishi d, Yasufumi Ohfune a, Tetsuro Shinada a, a Graduate School of Science, Osaka City University, 3-3-138, Sugimoto, Sumiyoshi, Osaka 558-8585, Japan b Bioorganic Research Institute, Suntory Foundation for Life Sciences, 8-1-1, Seikadai, Seika-cho, Soraku-gun, Kyoto 619-0284, Japan c National Institute of Advanced Industrial Science and Technology, 1-8-31, Midorigaoka, Ikeda, Osaka 563-8577, Japan d Analytical Chemistry, Pharmaceutical Science, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan article info abstract Article history: Kaitocephalin (KCP) isolated from Eupenicillium shearii PF1191 is an unusual amino acid natural product Received 17 May 2016 in which serine, proline, and alanine moieties are liked with carbon–carbon bonds. KCP exhibits potent Revised 8 June 2016 and selective binding affinity for one of the ionotropic glutamate receptor subtypes, NMDA receptors Accepted 9 June 2016 (K = 7.8 nM). In this study, new structure–activity relationship studies at C9 of KCP were implemented. Available online 11 June 2016 i Eleven new KCP analogs with different substituents at C9 were prepared and employed for binding affin- ity tests using native ionotropic glutamate receptors. Replacement of the 3,5-dichloro-4-hydroxybenzoyl Keywords: group of KCP with a 3-phenylpropionyl group resulted in significant loss of binding affinity for NMDARs Ionotropic glutamate receptors (K = 1300 nM), indicating an indispensable role of the aromatic ring of KCP in the potent and selective Kaitocephalin i Natural product binding to NMDARs.
    [Show full text]
  • Comprehensive Review on the Interaction Between Natural Compounds and Brain Receptors: Benefits and Toxicity
    European Journal of Medicinal Chemistry 174 (2019) 87e115 Contents lists available at ScienceDirect European Journal of Medicinal Chemistry journal homepage: http://www.elsevier.com/locate/ejmech Review article Comprehensive review on the interaction between natural compounds and brain receptors: Benefits and toxicity * Ana R. Silva a, Clara Grosso b, , Cristina Delerue-Matos b,Joao~ M. Rocha a, c a Centre of Molecular and Environmental Biology (CBMA), Department of Biology (DB), University of Minho (UM), Campus Gualtar, P-4710-057, Braga, Portugal b REQUIMTE/LAQV, Instituto Superior de Engenharia do Instituto Politecnico do Porto, Rua Dr. Antonio Bernardino de Almeida, 431, P-4249-015, Porto, Portugal c REQUIMTE/LAQV, Grupo de investigaçao~ de Química Organica^ Aplicada (QUINOA), Laboratorio de polifenois alimentares, Departamento de Química e Bioquímica (DQB), Faculdade de Ci^encias da Universidade do Porto (FCUP), Rua do Campo Alegre, s/n, P-4169-007, Porto, Portugal article info abstract Article history: Given their therapeutic activity, natural products have been used in traditional medicines throughout the Received 6 December 2018 centuries. The growing interest of the scientific community in phytopharmaceuticals, and more recently Received in revised form in marine products, has resulted in a significant number of research efforts towards understanding their 10 April 2019 effect in the treatment of neurodegenerative diseases, such as Alzheimer's (AD), Parkinson (PD) and Accepted 11 April 2019 Huntington (HD). Several studies have shown that many of the primary and secondary metabolites of Available online 17 April 2019 plants, marine organisms and others, have high affinities for various brain receptors and may play a crucial role in the treatment of diseases affecting the central nervous system (CNS) in mammalians.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
    US 20150202317A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau et al. (43) Pub. Date: Jul. 23, 2015 (54) DIPEPTDE-BASED PRODRUG LINKERS Publication Classification FOR ALPHATIC AMNE-CONTAINING DRUGS (51) Int. Cl. A647/48 (2006.01) (71) Applicant: Ascendis Pharma A/S, Hellerup (DK) A638/26 (2006.01) A6M5/9 (2006.01) (72) Inventors: Harald Rau, Heidelberg (DE); Torben A 6LX3/553 (2006.01) Le?mann, Neustadt an der Weinstrasse (52) U.S. Cl. (DE) CPC ......... A61K 47/48338 (2013.01); A61 K3I/553 (2013.01); A61 K38/26 (2013.01); A61 K (21) Appl. No.: 14/674,928 47/48215 (2013.01); A61M 5/19 (2013.01) (22) Filed: Mar. 31, 2015 (57) ABSTRACT The present invention relates to a prodrug or a pharmaceuti Related U.S. Application Data cally acceptable salt thereof, comprising a drug linker conju (63) Continuation of application No. 13/574,092, filed on gate D-L, wherein D being a biologically active moiety con Oct. 15, 2012, filed as application No. PCT/EP2011/ taining an aliphatic amine group is conjugated to one or more 050821 on Jan. 21, 2011. polymeric carriers via dipeptide-containing linkers L. Such carrier-linked prodrugs achieve drug releases with therapeu (30) Foreign Application Priority Data tically useful half-lives. The invention also relates to pharma ceutical compositions comprising said prodrugs and their use Jan. 22, 2010 (EP) ................................ 10 151564.1 as medicaments. US 2015/0202317 A1 Jul. 23, 2015 DIPEPTDE-BASED PRODRUG LINKERS 0007 Alternatively, the drugs may be conjugated to a car FOR ALPHATIC AMNE-CONTAINING rier through permanent covalent bonds.
    [Show full text]
  • Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems ELENI BAGLI 1,2 , ANNA GOUSSIA 3, MARILITA M
    in vivo 30 : 535-548 (2016) Review Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems ELENI BAGLI 1,2 , ANNA GOUSSIA 3, MARILITA M. MOSCHOS 4, NIKI AGNANTIS 3 and GEORGIOS KITSOS 2 1Institute of Molecular Biology and Biotechnology - FORTH, Division of Biomedical Research, Ioannina, Greece; 2Department of Ophthalmology, University of Ioannina, Ioannina, Greece; 3Department of Pathology, University of Ioannina, Ioannina, Greece; 4Department of Ophthalmology, University of Athens, Athens, Greece Abstract. Neurodegeneration characterizes pathologic pathological events, including oxidative stress, mitochondrial conditions, ranging from Alzheimer’s disease to glaucoma, dysfunction, inflammation and protein aggregation (2, 3). with devastating social and economic effects. It is a The increasing knowledge of the cellular and molecular complex process implicating a series of molecular and events underlying the degenerative process has greatly cellular events, such as oxidative stress, mitochondrial stimulated research for identifying compounds capable of dysfunction, protein misfolding, excitotoxicity and stopping or, at least, slowing the progress of neural inflammation. Natural compounds, because of their broad deterioration. spectrum of pharmacological and biological activities, Natural compounds are complex chemical multiple-target could be possible candidates for the management of such molecules found mainly in plants and microorganisms (4). multifactorial morbidities. However, their therapeutic These agents
    [Show full text]
  • Vol 32 No. 3.Cdr
    Chemistry in Sri Lanka ISSN 1012 - 8999 The Tri-Annual Publication of the Institute of Chemistry Ceylon Founded in 1971, Incorporated by Act of Parliament No. 15 of 1972 Successor to the Chemical Society of Ceylon, founded on 25th January 1941 Vol. 32 No. 3 September 2015 Pages Council 2015/2016 02 Outline of our Institute 02 Chemistry in Sri Lanka 02 Committees 2015/2016 03 Message from the President 04 Cover Page 04 Guest Editorial: Role of Professional Chemists for National Development 05 Presidential Address: Chemical Sciences in Food Safety and Food Security 06 Call for Nominations for Institute of Chemistry Gold Medal 2016 08 Forty Fourth Annual Sessions and Seventy Fourth Anniversary Celebrations 2015 Chief Guest’s Address: Chemical Sciences in Food Safety and Security 09 Guest of Honour’s Address: Chemists and Professionalism 11 Theme Seminar on “The Role of Chemistry in Food Safety and Food Security” Chief Guest’s Address: Food Safety 12 Food Security and Water Quality 14 Dr. C L De Silva Gold Medal Award 2015 Exploring Endolichenic Fungi in Sri Lanka as a Potential Treasure Trove for Bioactive Small Molecules; A Journey through the Fascinating World of endolichenic fungi 19 Chandrasena Memorial Award 2015 Lichens as a Treasure Chest of Bioactive Metabolites 30 Kandiah Memorial Graduateship Award 2015 Time Course Variation of Nutraceuticals and Antioxidant Activity during Steeping of CTC Black Tea (Camellia sinensis L.) Manufactured in Sri Lanka 34 Guest Articles The Asymmetric [C+NC+CC] Coupling Reaction: Development and Application
    [Show full text]
  • Organic & Biomolecular Chemistry
    Organic & Biomolecular Chemistry Accepted Manuscript This is an Accepted Manuscript, which has been through the Royal Society of Chemistry peer review process and has been accepted for publication. Accepted Manuscripts are published online shortly after acceptance, before technical editing, formatting and proof reading. Using this free service, authors can make their results available to the community, in citable form, before we publish the edited article. We will replace this Accepted Manuscript with the edited and formatted Advance Article as soon as it is available. You can find more information about Accepted Manuscripts in the Information for Authors. Please note that technical editing may introduce minor changes to the text and/or graphics, which may alter content. The journal’s standard Terms & Conditions and the Ethical guidelines still apply. In no event shall the Royal Society of Chemistry be held responsible for any errors or omissions in this Accepted Manuscript or any consequences arising from the use of any information it contains. www.rsc.org/obc Page 1 of 5 OrganicPlease & Biomoleculardo not adjust margins Chemistry Journal Name COMMUNICATION (7 S)-Kaitocephalin as a potent NMDA receptor selective ligand Yoko Yasuno a, Makoto Hamada a, Masanori Kawasaki a, Keiko Shimamoto b, Yasushi, Shigeri c, Received 00th January 20xx, Toshifumi Akizawa d, Motomi Konishi d, Yasufumi, Ohfune a, Tetsuro Shinada a* Accepted 00th January 20xx Manuscript DOI: 10.1039/x0xx00000x www.rsc.org/ Structure-activity relationship (SAR) study of kaitocephalin known from the glutamate overstimulation using NMDA antagonists to be a potent naturally occuring NMDA receptor ligand was has become a promising strategy for drug discovery of these performed.
    [Show full text]
  • WO 2010/000073 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 7 January 2010 (07.01.2010) WO 2010/000073 Al (51) International Patent Classification: mond Street W , Apt. 903, Toronto, Ontario M5V 1Y5 C07D 417/12 (2006.01) A61P 25/02 (2006.01) (CA). DOVE, Peter [CA/CA]; 568 Palmerston Avenue, A61K 31/538 (2006.01) C07D 413/12 (2006.01) Toronto, Ontario M6G 2P7 (CA). MADDAFORD, A61K 31/5415 (2006.01) C07D 413/14 (2006.01) Shawn [CA/CA]; 3 179 Folkway Drive, Mississauga, On A61P 25/00 (2006.01) C07D 417/14 (2006.01) tario L5L 1Y3 (CA). RAKHIT, Suman [CA/CA]; 856 Hidden Grove Lane, Mississauga, Ontario L5H 4L2 (CA). (21) International Application Number: PCT/CA2009/000923 (74) Agents: CHATTERJEE, Alakananda et al; Gowling Lafleur Henderson LLP, P.O. Box 30, Suite 2300, 550 (22) International Filing Date: Burrard Street, Vancouver, British Columbia V6C 2B5 3 July 2009 (03.07.2009) (CA). English (25) Filing Language: (81) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (30) Priority Data: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, 61/133,887 3 July 2008 (03.07.2008) U S DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (71) Applicant (for all designated States except US): NEU- HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, RAXON, INC.
    [Show full text]
  • Novel Analgesic Triglycerides from Cultures of Agaricus Macrosporus
    J. Antibiot. 58(12): 775–786, 2005 THE JOURNAL OF ORIGINAL ARTICLE [_ ANTIBIOTICSJ Novel Analgesic Triglycerides from Cultures of Agaricus macrosporus and Other Basidiomycetes as Selective Inhibitors of Neurolysin Marc Stadler, Veronika Hellwig†, Anke Mayer-Bartschmid, Dirk Denzer, Burkhard Wiese, Nils Burkhardt Received: July 4, 2005 / Accepted: November 22, 2005 © Japan Antibiotics Research Association Abstract The agaricoglycerides are a new class of fungal secondary metabolites that constitute esters of Introduction chlorinated 4-hydroxy benzoic acid and glycerol. They are produced in cultures of the edible mushroom, Agaricus Neurolysin (EC 3.4.24.16) is a zinc metalloprotease that macrosporus, and several other basidiomycetes of the inactivates particular biologically active peptides, such as genera Agaricus, Hypholoma, Psathyrella and Stropharia. neurotensin and dynorphin A, by specific cleavage [1]. The main active principle, agaricoglyceride A, showed Whereas the kappa-opioid receptor agonist dynorphin A is strong activities against neurolysin, a protease involved in a well-known and obvious endogenous pain-relieving the regulation of dynorphin and neurotensin metabolism peptide, neurotensin has been reported to have analgesic ϭ (IC50 200 nM), and even exhibited moderate analgesic in properties when applied centrally in animal models [2]. vivo activities in an in vivo model. Agaricoglyceride Therefore, neurolysin inhibitors are likely to enhance the ϭ monoacetates (IC50 50 nM) showed even stronger in vitro analgesic properties of neurotensin and/or dynorphin A by activities. Several further co-metabolites with weaker or inhibiting cleavage and inactivation of these peptides. lacking bioactivities were also obtained and characterized. Accordingly, selective inhibitors of neurolysin are likely to Among those were further agaricoglyceride derivatives, as emphasize the analgesic effects of the aforementioned well as further chlorinated phenol derivatives such as the peptides, which accumulate if their inactivation is new compound, agaricic ester.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0234237 A1 MADDAFORD Et Al
    US 20080234237A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0234237 A1 MADDAFORD et al. (43) Pub. Date: Sep. 25, 2008 (54) QUINOLONE AND Related U.S. Application Data TETRAHYDROQUINOLONE AND RELATED COMPOUNDS HAVING NOS INHIBITORY (60) Provisional application No. 60/896,829, filed on Mar. ACTIVITY 23, 2007. (76) Inventors: Shawn MADDAFORD, Publication Classification Mississauga (CA); Jailall (51) Int. Cl. RAMNAUTH, Brampton (CA); A613/60 (2006.01) Suman RAKHIT, Mississauga C07D 409/4 (2006.01) (CA); Joanne PATMAN, A 6LX 3L/24709 (2006.01) Mississauga (CA); Subhash C. A6IP 25/06 (2006.01) ANNEDI, Mississauga (CA); John C07D 409/2 (2006.01) ANDREWS, Mississauga (CA): A6II 3/55 (2006.01) Peter DOVE, Toronto (CA); Sarah (52) U.S. Cl. ... 514/165; 54.6/158: 514/312: 514/212.07; SILVERMAN, Toronto (CA); Paul 540,523 Renton, Toronto (CA) (57) ABSTRACT Correspondence Address: CLARK & ELBNG LLP The present invention features quinolones, tetrahydroquino 101 FEDERAL STREET lines, and related compounds that inhibit nitric oxide synthase BOSTON, MA 02110 (US) (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS (21) Appl. No.: 12/054,083 isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can (22) Filed: Mar. 24, 2008 be used for treating or preventing various medical conditions. Standard Test Method for the Chung SNL Model of Thermal Hyperalgesia t = -7~-14 days to -30 II.in to 0 t 30, 60,90 & 120 min. - Baseline therinal paw Re-baseline Compound testing of therinal paw withdrawal, then L5/L6 thermal paw administration withdrawal using IR box as nerve ligation operation withdrawal by the i.p.
    [Show full text]
  • C+NC+CC] Coupling -Enabled Synthesis of Kaitocephalin
    ChemComm A concise [C+NC+CC] coupling -enabled synthesis of kaitocephalin Journal: ChemComm Manuscript ID: CC-COM-03-2014-001692.R1 Article Type: Communication Date Submitted by the Author: 26-Mar-2014 Complete List of Authors: Garner, Philip; Washington State University, Department of Chemistry Weerasinghe, Laksiri; Washington State University, Chemistry Van Houten, Ian; Washington State University, Chemistry Hu, Jieyu; Washington State University, Chemistry Page 1 of 4 ChemComm ChemComm RSCPublishing COMMUNICATION A concise [C+NC+CC] coupling-enabled synthesis of kaitocephalin Cite this: DOI: 10.1039/x0xx00000x Philip Garner,* Laksiri Weerasinghe, Ian Van Houten and Jieyu Hu Received 00th January 2012, Accepted 00th January 2012 DOI: 10.1039/x0xx00000x www.rsc.org/ A 15-step synthesis of the iGluR antagonist kaitocephalin of the aspartic acid-derived aldehyde 4, (S)-glycyl sultam 5, and from aspartic acid is reported. The linchpin pyrrolidine ring vinyl sulphone 6.9 The key C-C bond-forming step involves a [3+2] of the target molecule is efficiently assembled with in a single cycloaddition of a metalated azomethine ylide (formed in situ from 4 operation via an asymmetric [C+NC+CC] reaction. and 5) with an electronically-activated dipolarophile 6. The advantage of [C+NC+CC] coupling over other [3+2] cycloaddition Kaitocephalin is a natural product isolated from the fungus methodology stems from the ability to employ aliphatic aldehydes Eupenicillium shearii that was found to be a potent competitive such as 4 without enolization or enamine formation that would result 1 antagonist of ionotropic glutamate receptor (iGluR) activity. This in undesired side reactions. This limitation precludes the application property is of interest because glutamate receptors are the major of existing [3+2] dipolar cycloaddition technology to the excitatory neurotransmitter receptors in the vertebrate brain and are kaitocephalin pyrrolidine problem.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU Et Al
    US 20160O821 23A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0082123 A1 RAU et al. (43) Pub. Date: Mar. 24, 2016 (54) HYDROGEL-LINKED PRODRUGS (30) Foreign Application Priority Data RELEASING TAGGED DRUGS Apr. 22, 2013 (EP) .................................. 13164669.7 (71) Applicant: ASCENDIS PHARMA A/S, Hellerup Oct. 8, 2013 (EP) .................................. 13187784.7 (DK) Publication Classification (72) Inventors: Harald RAU, Dossenheim (DE); Nora KALUZA, Heidelberg (DE); Ulrich (51) Int. Cl. HERSEL, Heidelberg (DE); Thomas A647/48 (2006.01) KNAPPE, Heidelberg (DE); Burkhardt (52) U.S. Cl. LAUFER, Dossenheim (DE) CPC. A61 K47/48784 (2013.01); A61K 47/48215 2013.O1 (73) Assignee: Ascendis Pharma A/S, Hellerup (DK) ( ) (21) Appl. No.: 14/786,481 (57) ABSTRACT 1-1. The present invention relates to a process for the preparation (22) PCT Filed: Apr. 16, 2014 of a hydrogel-linked prodrug releasing a tag moiety-biologi (86). PCT No.: PCT/EP2014/057753 releasingcally active a tag moiety moiety-biologically conjugate, to a hydrogel-linked active moiety conjugate prodrug S371 (c)(1), obtainable by Such process, to pharmaceutical compositions (2) Date: Oct. 22, 2015 comprising said prodrug and their use as a medicament. US 2016/00821 23 A1 Mar. 24, 2016 HYDROGEL-LINKED PRODRUGS boxyl (-COOH) or activated carboxyl ( COY, RELEASING TAGGED DRUGS wherein Y is selected from formulas (fi) to (f-vi): FIELD OF THE INVENTION 0001. The present invention relates to a process for the (f-i) preparation of a hydrogel-linked prodrug releasing a tag moi ety-biologically active moiety conjugate, to a hydrogel linked prodrug releasing a tag moiety-biologically active moiety conjugate obtainable by Such process, to pharmaceu tical compositions comprising said prodrug and their use as a medicament.
    [Show full text]
  • A Study Into the Influence of Amyloid-Beta Peptide Oxidation on the Rate of Fibril Formation, with a Synthesis of 2-Oxo-Histidine
    A Study into the Influence of Amyloid-beta Peptide Oxidation on the Rate of Fibril Formation, with a Synthesis of 2-oxo-histidine Hannah Mary Garrett A thesis submitted to THE UNIVERSITY OF LONDON For the degree of DOCTOR OF PHILOSOPHY School of Biological and Chemical Sciences Queen Mary, University of London May 2012 I herewith certify that any material in this thesis that is not my own work has been properly acknowledged. Hannah Garrett 2 I dedicate this thesis to my family and friends but in particular to my late father, Christopher John Wright, who first showed me the wonder of science. 3 ACKNOWLEDGEMENTS Although a PhD thesis only has one name on the title page it is never a solo effort. There are so many people who have advised and supported me over the last four years and without them it is unlikely this thesis would be here. It is impossible to thank everyone who has made this possible but I would like to mention a few of these people. Firstly, I would like thank my two supervisors, Dr Peter Wyatt and Dr John Viles, for giving me the opportunity to undertake this project, for advising me throughout and for being a constant source of suggestions of how to go forward with the project when things didn’t quite go to plan. They have inspired me with their enthusiasm for their work and their breadth and depth of knowledge of their fields. Secondly, I would like to thank the other academics at Queen Mary who have advised and supported me throughout my PhD.
    [Show full text]